11/19/2025
Warning: Through anecdotal reports and observations from on-site drug testing at Carepoint Consumption & Treatment Services, we would like to share the following information about possible side effects that could be associated with red/orange fentanyl.
Through on-site drug testing, we are able to share that the following substances were detected in the fentanyl:
• Medetomidine
We have noticed reactions that include:
• Extended periods of heavy sedation
• Disorientation, including lost sense of time
• Unusual difficulty to rouse from a sleep-like state (AKA “a heavy nod”)
Harm reduction recommendations when using substances:
• Try not to use alone.
• If you use alone, tell someone where you are. Ask them to check on you. The National Overdose Response Service (NORS) is available as a confidential overdose prevention hotline providing compassionate, nonjudgmental support for people who use drugs alone: 1.888.688.6677.
• Use in small doses: Start low, go slow.
• Avoid mixing substances, if possible.
• Encourage use of Carepoint (Mon-Sun: 9:30 AM-8PM).
• Have naloxone ready and know how to respond to an overdose. Learn more at: Ontario.ca/Naloxone.
For more information, please contact Director of Harm Reduction Services, Megan Van Boheemen, at mvanboheemen@hivaidsconnection.ca or 226.377.8721.
Posted November 19, 2025. Please remove this notice by November 30, 2025 as the unregulated drug supply changes constantly.